Compare Moderna, Inc. (MRNA) vs Zillow Group Inc Class A (ZG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Zillow Group Inc Class A — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Zillow Group Inc Class A trades at $31.83 (market cap $7.54B). The key difference: Moderna, Inc. is far larger — about 3.1× Zillow Group Inc Class A's market cap, and Moderna, Inc. is trading nearer its 52-week high, Zillow Group Inc Class A nearer its low. Which is the better fit depends on your goals.
| MRNA | ZG | |
|---|---|---|
Market Cap | $23.60B | $7.54B |
Sector | Health | Media |
52-Week High | $81.80 | $86.76 |
52-Week Low | $22.36 | $29.14 |
Enterprise Value | $19.70B | $7.19B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Zillow Group Inc Class A
Zillow Group is an Internet-based real estate company that has historically focused on deriving ad revenue from third-party brokers on online marketplaces such as Zillow.com, Trulia, and HotPads. More recently it has shifted its focus to iBuying via the Zillow Offers platform.
Read more on ZG →
